Live Analyst Rating Changes 54325 upgrades, downgrades & price-target moves Β· freshest Wall Street data, updated daily View live feed β†’
Analyst Tracker/Christopher Kuplent
BofA

Christopher Kuplent

Wall Street Analyst
β˜…β˜…β˜…β˜†β˜†
#1552
on 13Foresight Β· ranked by our own returns
53%
Success Rate
+0.3%
Average Return
27 of 51 calls profitable Β· -3.7% vs benchmark
S&P 500 (SPY)
πŸ“ˆ Across the calls we could measure, roughly 53% of Christopher Kuplent's ratings turned a profit when each position was held for 1 year β€” averaging +0.3% per rating. These figures are computed by 13Foresight from historical prices, not supplied by the analyst.

Rating Distribution

25 Buy 27 Hold 15 Sell
Christopher's Stock Coverage 17 ratings Β· 2026-11-19
Company Date Position Consensus β“˜ Price Target β“˜ 1-Yr Return vs S&P 500 β“˜
FR:TTE
TotalEnergies SE
Oct 30, 2026 BUY Strong Buy
-3.3% avg upside
28 analysts
$89.00
4.23% Upside
-1.7% Β·
GB:SHEL
Shell (UK)
Oct 30, 2026 HOLD Strong Buy
+316.4% avg upside
27 analysts
$3950.00
2.08% Downside
-7.8% Β·
EQNR
Equinor ASA
Oct 30, 2026 BUY Hold
+13.6% avg upside
17 analysts
$52.13
6.87% Upside
-14.2% Β·
SHEL
Shell
Oct 30, 2026 HOLD Buy
-16.6% avg upside
27 analysts
$107.00
1.63% Downside
-12.5% Β·
GB:0M2Z
Equinor ASA
Oct 29, 2026 BUY Hold
-22.5% avg upside
26 analysts
$480.00
8.51% Upside
Β· Β·
IT:ENI
ENI S.p.A.
Oct 26, 2026 HOLD Buy
-14.9% avg upside
23 analysts
$26.50
2.38% Downside
-2.3% Β·
E
Eni SPA
Oct 16, 2026 HOLD Buy
-50.6% avg upside
16 analysts
$56.00
7.85% Downside
-4.3% Β·
BP
BP
Oct 16, 2026 SELL Buy
-7.7% avg upside
31 analysts
β€” +9.7% Β·
GB:BP
BP p.l.c.
Oct 14, 2026 SELL Strong Buy
+269.3% avg upside
30 analysts
$525.00
16.31% Downside
+5.8% Β·
TS
Tenaris SA
Oct 05, 2026 BUY Buy
-22.4% avg upside
23 analysts
$71.00
17.70% Upside
+1.3% Β·
GB:0O46
Neste Corporation
Sep 26, 2025 SELL Buy
+17.7% avg upside
20 analysts
$16.00
43.12% Downside
Β· Β·
IT:TEN
Tenaris
Jul 21, 2025 SELL Buy
-34.7% avg upside
12 analysts
$16.00
40.45% Downside
-65.5% Β·
GB:0OGK
Subsea 7
Jan 29, 2025 SELL Buy
-1.8% avg upside
17 analysts
$190.00
40.91% Downside
-42.1% Β·
IT:SPM
Saipem SpA
Jan 29, 2025 BUY Strong Buy
-8.3% avg upside
14 analysts
$3.50
21.81% Downside
+43.2% Β·
FR:VK
Vallourec
Jan 29, 2025 HOLD Buy
+17.1% avg upside
7 analysts
$20.00
6.74% Upside
+8.1% Β·
ES:REP
Repsol
Dec 07, 2023 SELL Buy
-30.4% avg upside
22 analysts
$12.00
60.95% Downside
+13.7% Β·
GB:0B67
GALP Energia SGPS
Dec 07, 2023 SELL Buy
-0.3% avg upside
17 analysts
$9.00
56.69% Downside
-25.3% Β·
πŸ”’ 12 more ratings β€” with price targets, crowd consensus and our measured returns.
Free account unlocks every analyst's full coverage table.
Christopher Kuplent β€” Frequently Asked Questions
How accurate are Christopher Kuplent's stock ratings?
Based on the calls 13Foresight could measure, about 53% of Christopher's ratings were profitable over a one-year hold, with an average return of +0.3% per rating, or -3.7% versus the S&P 500. We score every analyst the same way, from historical prices. Each return is measured in the stock's own trading currency, so for non-US listings the S&P 500 comparison leaves out currency moves.
How is Christopher ranked on 13Foresight?
Christopher Kuplent is currently ranked #1552 with a 3-star rating. Our rank blends hit rate, average return versus the market, and how many calls we have to judge β€” so a long, consistent record outweighs a few lucky picks. It is our own calculation, updated daily.
Which stocks does Christopher cover?
Christopher most recently has ratings on FR:TTE, GB:SHEL, EQNR, SHEL, GB:0M2Z, IT:ENI, E, BP, GB:BP, TS, GB:0O46, IT:TEN and 5 more. See the full coverage table above for positions, price targets and our measured returns.
Where can I see other analyst ratings?
Browse the full analyst leaderboard to compare Wall Street analysts ranked by their measured performance, success rate and average return.

Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.